Larimar Therapeutics, Inc. (LRMR) - Latest Market Data

Price & Market Data

Price: $3.02

Daily Change: -$0.09 / 2.98%

Daily Range: $2.90 - $3.07

Market Cap: $254,203,472

Daily Volume: 873,375

Performance Metrics

1 Week: -7.48%

1 Month: -10.54%

3 Months: -12.39%

6 Months: -21.22%

1 Year: -9.17%

YTD: -22.05%

Company Details

Employees: 65

Sector: Health technology

Industry: Biotechnology

Country:

Details

Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 2 OLE clinical trial for the treatment of Friedreich's ataxia, a rare, progressive and fatal genetic disease. The company is based in Bala Cynwyd, Pennsylvania.

Selected stocks

LXP Industrial Trust (LXP)

LyondellBasell Industries NV (LYB)

Gladstone Investment Corporation - 5.00% Notes Due 2026 (GAINN)